Müller M, Meijer C, Zaman G J, Borst P, Scheper R J, Mulder N H, de Vries E G, Jansen P L
Department of Gastroenterology and Hepatology, University Hospital Groningen, The Netherlands.
Proc Natl Acad Sci U S A. 1994 Dec 20;91(26):13033-7. doi: 10.1073/pnas.91.26.13033.
The multidrug resistance-associated protein (MRP) is a 180- to 195-kDa glycoprotein associated with multidrug resistance of human tumor cells. MRP is mainly located in the plasma membrane and it confers resistance by exporting natural product drugs out of the cell. Here we demonstrate that overexpression of the MRP gene in human cancer cells increases the ATP-dependent glutathione S-conjugate carrier activity in plasma membrane vesicles isolated from these cells. The glutathione S-conjugate export carrier is known to mediate excretion of bivalent anionic conjugates from mammalian cells and is thought to play a role in the elimination of conjugated xenobiotics. Our results suggest that MRP can cause multidrug resistance by promoting the export of drug modification products from cells and they shed light on the reported link between drug resistance and cellular glutathione and glutathione S-transferase levels.
多药耐药相关蛋白(MRP)是一种180至195千道尔顿的糖蛋白,与人类肿瘤细胞的多药耐药性相关。MRP主要位于质膜,通过将天然产物药物输出细胞外而赋予耐药性。在此我们证明,人类癌细胞中MRP基因的过表达会增加从这些细胞分离出的质膜囊泡中依赖ATP的谷胱甘肽S-共轭物载体活性。谷胱甘肽S-共轭物输出载体已知可介导二价阴离子共轭物从哺乳动物细胞的排泄,并被认为在共轭异生物的消除中起作用。我们的结果表明,MRP可通过促进药物修饰产物从细胞中输出而导致多药耐药,并且为报道的耐药性与细胞谷胱甘肽及谷胱甘肽S-转移酶水平之间的联系提供了线索。